Controversial new state law takes aim at excessive pharma prices

Hettie O'Brien

21 February 2018

Credit: istock/FotografiaBasica

In his battle against high drug prices, Joshua Auerbach has faced down his mission’s detractors.

Subscribe to Global Competition Review

Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.

Subscribe now

View full biography

Author

[email protected]

Big Toy: The Tipline for 11 December 2023
The Chevron/Hess merger is not a killer acquisition, at least not where holiday toys are concerned. The merging energy companies have committed to continuing the annual release of new Hess Toy Trucks models. While Chevron targets toddlers with its own plastic fossil fuel propaganda, it's safe to assume the in-depth probe the Federal Trade Commission opened last week into the deal delves into a much bigger market.
Duking it out: The Tipline for 8 December 2023
Amateurism hour: The Tipline for 7 December 2023